AMERICAN CENTURY COMPANIES INC
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 748054
KANSAS CITY, MO
Position in ACAD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,635,306
+$1,870,845 QoQ
Shares Held
143,688
+81.3% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 354 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,618,743,392 across 179 Biotechnology names. ACAD ranks #59 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in ACAD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,635,306 | 143,688 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,764,461 | 79,266 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,445,536 | 128,998 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,926,436 | 418,296 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $33,808,559 | 1,567,388 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $27,119,960 | 1,632,749 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,592,212 | 141,265 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,399,995 | 91,027 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,188,655 | 73,148 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $765,227 | 41,386 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $2,773,720 | 133,096 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $383,295 | 16,004 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $459,601 | 32,619 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,071,202 | 44,228 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,052,820 | 45,108 | Shares | Defined | 2022-02-07 | |
| 2021-03-31 | $6,411,429 | 248,505 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $64,637,256 | 1,209,077 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $49,741,147 | 1,205,846 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $53,236,782 | 1,098,345 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $39,184,128 | 927,435 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||